What is Aerobiotix?
Aerobiotix, Inc. is a key player in the advanced air quality sector, dedicated to developing and manufacturing novel technologies that improve healthcare environments worldwide. Founded in 2013 and headquartered in Miamisburg, Ohio, the company aims to raise awareness about the critical role of air quality in preventing hospital-acquired infections. Aerobiotix provides effective devices designed to enhance patient and caregiver safety, positioning itself as a leader in building better healthcare settings globally.
How much funding has Aerobiotix raised?
Aerobiotix has raised a total of $38.4M across 3 funding rounds:
Debt
$350K
Unspecified
$25M
Debt
$13M
Debt (2020): $350K with participation from PPP
Unspecified (2021): $25M led by Vivo Capital and Asahi Kasei Ventures
Debt (2022): $13M supported by Vivo Capital, Asahi Medialab Ventures, and Horizon Technology Finance
Key Investors in Aerobiotix
Vivo Capital
Vivo Capital, founded in 1996 and headquartered in Palo Alto, California, is a global healthcare investment firm focused on private and public equity as well as venture capital.
Asahi Medialab Ventures
AsahiMediaLabVentures is a venture capital firm that broadly invests in internet-related companies, focusing primarily on seed and early-stage ventures, regardless of their media or synergy aspects.
Horizon Technology Finance
Horizon Technology Finance is a specialty finance company providing structured debt financing solutions to development-stage companies, primarily in technology and life sciences sectors.
What's next for Aerobiotix?
The substantial enterprise-level funding and recent strategic investment indicate Aerobiotix is poised for significant scaling and market expansion. This capital infusion is likely to accelerate product development, enhance manufacturing capabilities, and broaden the company's reach in the global healthcare market. Aerobiotix's focus on addressing hospital-acquired infections through superior air quality solutions aligns with growing industry and regulatory emphasis on patient safety and infection control, suggesting a strong future for the company's innovative technologies.
See full Aerobiotix company page
